Arcellx Incorporated (NASDAQ:ACLX) is one of 17 biotechnology stocks with more than 50% upside. On February 12, Qize Ding from Rothschild & Co Redburn downgraded the rating on Arcellx Incorporated (NASDAQ:ACLX) from Buy to Neutral. In the process, he also reduced the price target from $113 to $82, which still yields a revised upside potential of almost 20%. Ding’s views are based on his conservative stance on the company’s CAR-T cell therapy class amid rising competition across larger markets in other mod ...

Core Insights - Apogee Therapeutics (NASDAQ:APGE) is identified as one of the 17 biotechnology stocks with more than 50% upside potential, with a current price target of $95 set by Citi analyst Geoff Meacham, indicating a potential upside of over 37% [1] - RBC Capital analyst Brian Abrahams downgraded Apogee Therapeutics from Outperform to Sector Perform, while raising the price target from $70 to $83, suggesting nearly 20% upside [2] - The market reaction to the release of Sanofi's Phase 3 amlitelimab data is viewed as an overreaction, with Meacham asserting that it does not negatively impact the prospects for Apogee's APG279 candidate [1] Company Overview - Apogee Therapeutics is a clinical-stage biotechnology company focused on developing novel biologics for treating inflammatory and immune diseases, including atopic dermatitis, asthma, chronic obstructive pulmonary disease, and eosinophilic esophagitis [4] - The company's pipeline includes several candidates at different clinical trial stages, such as APG777, APG279, APG990, APG333, and APG808 [4] Market Context - The segment in which Apogee operates is becoming increasingly competitive, with established players posing challenges despite the potential of its primary drug, zumilokibart, as a long-acting IL-13 treatment for atopic dermatitis [3] - The share price of Apogee has surged by 108% over the past year, which may limit the potential for further gains [3]

The iShares Morningstar Small-Cap ETF ((NYSEMKT:ISCB)) and Vanguard Small-Cap ETF ((NYSEMKT:VB)) both offer broad U.S. small-cap exposure, but ISCB delivered stronger recent returns and holds more names, while VB is far larger, more liquid, and a touch less volatile. Both the iShares Morningstar Small-Cap ETF and Vanguard Small-Cap ETF aim to track the U.S. small-cap segment, providing investors with diversified access to hundreds of smaller companies. This comparison looks at how ISCB’s portfolio and ris ...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Scientific SE (EUFI.PA) (Paris:ERF) has received various notifications of dealing from Persons Discharging Managerial Responsibilities ("PDMR†). The notification of Dealing Form for each PDMR can be found below. This notification is made in accordance with the European Market Abuse Regulation. NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM   1. Details of the p. ...

On February 12, 2026, Barington Companies Management disclosed a new position in Americold Realty Trust (NYSE:COLD), acquiring 300,000 shares in a transaction estimated at $3.86 million based on quarterly average pricing. What happened According to a SEC filing dated February 12, 2026, Barington Companies Management reported establishing a new position in Americold Realty Trust by purchasing 300,000 shares during the fourth quarter. The quarter-end value of the stake stood at $3.86 million, reflecting th ...

Turning 65 is a major milestone for one big reason -- it's when you're eligible for health coverage under Medicare. But if you're still working at age 65, Medicare coverage may not be necessary. If your job provides you with health insurance, you may still be able to sign up for Medicare and use it as secondary insurance. But that also may not be necessary. And since there's a cost to Medicare Part B, if you're still working at 65, you may decide to delay your enrollment. Will AI create the world's first ...

Core Insights - Live Nation Entertainment, Inc. (LYV) is set to report its fourth-quarter 2025 results on February 19, after market close [1] - The company's adjusted earnings per share (EPS) for the last reported quarter missed the Zacks Consensus Estimate by 39.7% and declined 56% year over year, while revenues missed the consensus mark by 0.6% but increased 11% year over year [1] Earnings Performance - LYV's earnings exceeded the consensus estimate in two of the last four quarters, while missing in the other two, with an average surprise of 13.5% [2] Earnings Estimates - The Zacks Consensus Estimate for the fourth-quarter loss has widened to $1.02 per share from a previous estimate of a loss of 97 cents, compared to an adjusted EPS of 56 cents in the same quarter last year [3] - Revenue estimates for the fourth quarter are projected at $6.07 billion, reflecting a 6.9% increase from $5.68 billion reported in the prior year [3] Revenue Drivers - The anticipated revenue growth in the fourth quarter is attributed to pent-up demand for live events and strong ticket sales, supported by high attendance at large venues and sustained international demand [4] - Concert revenues are expected to rise by 7.5% year over year to $4.9 billion, while Sponsorship and Advertising revenues are projected to increase by 15.2% to $324 million, and Ticketing revenues by 4.2% to $876.2 million [5] Cost Pressures - Increased labor-hiring costs, artist activation costs, and other operational expenses are likely to negatively impact LYV's bottom line for the quarter [6] - The company is also facing rising venue costs and service fees, with caution regarding cost overruns related to the development and expansion of live music venues [6] Earnings Prediction Model - The current model does not predict an earnings beat for Live Nation Entertainment, as it has an Earnings ESP of -15.45% and a Zacks Rank of 5 (Strong Sell) [7][8]

Core Insights - Cadence Design Systems, Inc. (CDNS) is set to release its fourth-quarter results for 2025 on February 17, with earnings per share (EPS) expected at $1.90 and revenues at $1.42 billion, reflecting a 1.1% increase in EPS and nearly 5% growth in revenues year-over-year [1][2] Financial Performance - The management anticipates fourth-quarter revenues to be between $1.405 billion and $1.435 billion, compared to $1.356 billion in the same quarter last year [2] - For the full year 2025, revenues are projected to be in the range of $5.262 billion to $5.292 billion, with non-GAAP EPS expected between $7.02 and $7.08 [3] - The company has a strong earnings surprise history, beating the Zacks Consensus Estimate in each of the last four quarters with an average surprise of 5.4% [3] Stock Performance - CDNS stock has increased by 1.5% over the past year, contrasting with a 10.4% decline in the Computer-Software industry, while the S&P 500 composite and the Zacks Computer and Technology sector have risen by 18.2% and 14.1%, respectively [6] Market Factors - Ongoing global macroeconomic uncertainties, particularly U.S.-China tech tensions, along with competition in the EDA space and inflation, are concerns ahead of the fourth-quarter earnings [7] - The demand for AI-driven design solutions is significantly influencing Cadence's performance, with strong activity in sectors such as data centers, drones, robotics, and automotive [8][10] Product and Service Developments - Cadence has expanded its AI and IP portfolio through new launches, partnerships, and acquisitions in 2025, benefiting from a $7 billion backlog and increased R&D spending [8][11] - The core EDA business is expected to gain from demand for new hardware systems, particularly among AI, automotive, and high-performance computing clients [13] - Recent product launches, including the ChipStack AI Super Agent and Tensilica HiFi iQ DSP IP, are designed to address the complexities of modern chip architectures and enhance performance in voice AI and immersive audio applications [19][20] Strategic Collaborations - Cadence is collaborating with major tech companies like Qualcomm and NVIDIA on next-generation AI designs, which is expected to enhance its market position [12] - The acquisition of the Design & Engineering division of Hexagon AB is anticipated to accelerate Cadence's footprint expansion in various sectors, including automotive and aerospace [16][17]

Core Insights - Charles Schwab (SCHW) reported total client assets of $12.15 trillion in January 2026, reflecting a 17.6% increase year-over-year and a 2.1% increase sequentially, attributed to market volatility [1][7] - The company's core net new assets (NNA) were $27.8 billion, which is a decrease of 9.2% from January 2025 and a significant drop of 64.9% from December 2025 [1][7] Performance Breakdown - Client assets under ongoing advisory services reached $6.16 trillion, marking an 18.6% increase from the previous year and a 2.3% increase from the prior month [2] - Average interest-earning assets rose to $441.7 billion, up 2.4% year-over-year and 1.3% sequentially [2] - Margin balances increased to $116.3 billion, showing a 40.3% rise from January 2025 and a 3.6% increase from December 2025 [2][7] Account Activity - The company opened 476,000 new brokerage accounts in January 2026, which is a 9.9% increase compared to the same month last year and stable compared to the previous month [3] - Active brokerage accounts totaled 38.7 million at the end of January 2026, up 5.5% year-over-year and slightly from December 2025 [4] - Client banking accounts reached 2.23 million, reflecting a 10.9% increase from January 2025 and a 1.1% increase sequentially [4] - Workplace plan participant accounts rose to 5.79 million, up 6.3% year-over-year and marginally from December 2025 [4] Market Comparison - In the past three months, Schwab shares have gained 2%, while the industry has seen a growth of 4.5% [5]

Core Viewpoint - The content emphasizes the importance of conducting personal due diligence and consulting with competent advisors before making any financial decisions, particularly in the context of investments in complex instruments like cryptocurrencies and CFDs [1]. Group 1 - The website provides general news, personal analysis, and third-party materials intended for educational and research purposes [1]. - It explicitly states that the information should not be interpreted as a recommendation or advice for investment actions [1]. - The accuracy and reliability of the information are not guaranteed, and users are cautioned against relying solely on the content provided [1]. Group 2 - The website discusses the high risks associated with cryptocurrencies and CFDs, highlighting their complexity and the potential for significant financial loss [1]. - It encourages users to conduct their own research and fully understand the instruments and risks involved before making investment decisions [1].